December 2, 2025
Announcement
Initially announced on August 20, 2025 XOMA CORP made a cash offer for MURAL ONCOLOGY PLC of USD 2.035 per MURAL ONCOLOGY PLC share held. Pending the completion of customary closing conditions, the Acquisition is expected to be completed on December 5, 2025. Trading in shares of MURAL ONCOLOGY PLC is expected to be halted effective December 5, 2025.
The treatment below will be applied to the following indices:
Solactive US Extended Broad Market Index (GTR)
Solactive GBS United States Large & Mid Cap Equal Weight Index NTR
Solactive GBS United States Large & Mid Cap Equal Weight Index PR
Solactive GBS United States Large & Mid Cap Equal Weight Index TR
US M&A Basket
We work closely with our internal partners to deliver investment ideas that generate demonstrable value for our clients.